Nanoneedle-Based Transdermal Gene Delivery: A Minimally Invasive Strategy for Gene Therapy
International Journal of Molecular Sciences · 27.06.2025 · 26 (13) · 6235
DOI: 10.3390/ijms26136235 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.06.2025. Verfasst von Fatma Julide Akbuğa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology, School of Pharmacy, Istanbul Medipol University, 34815 İstanbul, Türkiye. Hauptthemen laut MEDLINE: Genetic Therapy, Gene Transfer Techniques, Nanotechnology, Nanostructures. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Transdermal drug delivery systems have recently been explored as an alternative to oral systems, which have many challenges. Due to the limitations of first-generation transdermal systems, second- and third-generation systems have been developed, among which microneedles have been the most remarkable products. Building on the advancements of nanotechnology, nanoneedles have recently been developed. Gene therapy molecules—such as DNA, RNA, siRNA, miRNA, and other nucleic acids—are typically delivered using viral or chemical carriers, but these methods face several challenges. In this context, nanoneedles offer a promising and efficient solution for delivering these large molecules. Nanoneedles are a biocompatible and reliable physical method for gene delivery, enabling transdermal administration by penetrating the skin barrier and delivering nucleic acids directly into cells. Their ability to penetrate cellular barriers with minimal invasiveness makes them advantageous for delivering genetic materials. This review will focus on the potential applications of nanoneedles in pharmaceutical contexts, especially in gene therapy. In addition, information on the properties, structure, and fabrication of nanoneedles is also provided.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Technology, School of Pharmacy, Istanbul Medipol University, 34815 İstanbul, Türkiye.
- Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Inonu University, 44280 Malatya, Türkiye.
ORCID-Profile: Fatma Julide Akbuğa, Muhammet Davut Arpa
Zitieren
APA
Akbuğa, F. J., Arpa, M. D., & Şalva, E. (2025). Nanoneedle-Based Transdermal Gene Delivery: A Minimally Invasive Strategy for Gene Therapy. International Journal of Molecular Sciences, 26(13), 6235. https://doi.org/10.3390/ijms26136235
Vancouver
Akbuğa FJ, Arpa MD, Şalva E. Nanoneedle-Based Transdermal Gene Delivery: A Minimally Invasive Strategy for Gene Therapy. International Journal of Molecular Sciences. 2025;26(13):6235. doi:10.3390/ijms26136235
BibTeX
@article{Akbua2025,
author = {Akbuğa, Fatma Julide and Arpa, Muhammet Davut and Şalva, Emine},
title = {Nanoneedle-Based Transdermal Gene Delivery: A Minimally Invasive Strategy for Gene Therapy},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {13},
pages = {6235},
doi = {10.3390/ijms26136235}
}
EUVIMED